SCHEMBL2726770

SCHEMBL2726770

[CH2]c1cncnc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28866132 0.70 — —
SCHEMBL25403015 0.69 — —
SCHEMBL3050114 0.68 — —
SCHEMBL13261991 0.68 — —
SCHEMBL1760847 0.68 — —
SCHEMBL25403737 0.68 — —
SCHEMBL25402182 0.68 — —
SCHEMBL25403109 0.68 — —
SCHEMBL25403717 0.68 — —
SCHEMBL8313228 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2632908-B1 SULFONAMIDES AS HIV PROTEASE INHIBITORS MERCK CANADA INC (CA) 2016-05-25 — — EP claimed
US-9187415-B2 Sulfonamides as HIV protease inhibitors MERCK CANADA INC. (CA) 2015-11-17 — — US claimed
US-20140018326-A1 SULFONAMIDES AS HIB PROTEASE INHIBITORS MERCK CANADA INC. (CA) 2014-01-16 — — US claimed
EP-2632908-A1 SULFONAMIDES AS HIV PROTEASE INHIBITORS Merck Canada Inc. (CA) 2013-09-04 — — EP claimed
WO-2012055034-A1 SULFONAMIDES AS HIV PROTEASE INHIBITORS MERCK CANADA INC. (CA) 2012-05-03 — — WO claimed
WO-2024071216-A1 PYRAZOLE COMPOUND AND PEST CONTROL AGENT CONTAINING SAME AS ACTIVE INGREDIENT 三井化学クロップ&ライフソリューション株式会社 2024-04-04 — — WO disclosed
WO-2023171783-A1 PYRAZOLE COMPOUND, AND NOXIOUS ORGANISM CONTROL AGENT CONTAINING SAME AS ACTIVE INGREDIENT 三井化学アグロ株式会社 2023-09-14 — — WO disclosed
EP-2632908-B1 SULFONAMIDES AS HIV PROTEASE INHIBITORS MERCK CANADA INC (CA) 2016-05-25 — — EP disclosed
US-9187415-B2 Sulfonamides as HIV protease inhibitors MERCK CANADA INC. (CA) 2015-11-17 — — US disclosed
US-20140018326-A1 SULFONAMIDES AS HIB PROTEASE INHIBITORS MERCK CANADA INC. (CA) 2014-01-16 — — US disclosed
EP-2632908-A1 SULFONAMIDES AS HIV PROTEASE INHIBITORS Merck Canada Inc. (CA) 2013-09-04 — — EP disclosed
WO-2012055034-A1 SULFONAMIDES AS HIV PROTEASE INHIBITORS MERCK CANADA INC. (CA) 2012-05-03 — — WO disclosed
Send feedback